BeiGene
BGNEBeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. Founded in Beijing in 2010 by Xiaodong Wang and chief executive officer John V. Oyler, the company has offices in China, the United States, Australia and Europe. BeiGene has developed several pharma …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at BeiGene
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/11/2024 | Sell | Oyler, John | Chief Executive Officer | $146.9 | $1,773,085 |
| 4/10/2024 | Sell | Oyler, John | Chief Executive Officer | $149.6 | $3,977,862 |
| 4/9/2024 | Sell | Oyler, John | Chief Executive Officer | $153.3 | $1,724,077 |
| 3/13/2024 | Sell | Oyler, John | Chief Executive Officer | $179.9 | $2,189,647 |
| 3/12/2024 | Sell | Oyler, John | Chief Executive Officer | $165.3 | $6,178,369 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)